Refolding Record:
Protein | |
---|---|
Protein Name | Proteinase inhibitor PSKP-1 |
Abbreviated Name | PSKP-1 |
SCOP Family | Unknown |
Structure Notes | |
Organism | Phyllomedusa sauvagei (Sauvage\'s leaf frog) |
UniProt Accession | P83578 |
SCOP Unique ID | n/a |
Structure Solved | |
Class | Unknown |
Molecularity | Monomer |
Construct | |
---|---|
Full Length | y |
Domain | n/a |
Chimera | n/a |
Variants | n/a |
Chain Length | 58 |
Molecular Weight | 6702.0 |
Pi | 9.34 |
Molecular Weight | 6702.0 |
Disulphides | 3 |
Full Sequence |
VIEPKCYKYEGKKCPPDINPVCGTDKRTYYNECALCVFIRQSTKKADKAIKIKKWGKC
|
Notes | n/a |
Expression | |
---|---|
Report | Gebhard LG, Carrizo FU, Stern AL, Burgardt NI, Faivovich J, Lavilla E, Ermácora MR. (2004) Eur J Biochem., 271, 2117-2126 |
Project Aim | Protein isolation |
Fusion | None |
Protein Expression and Production | Protein recombinantly expressed as and refolded from inclusion bodies. |
Expression Host | Escherichia coli |
Expression Strain | BL21(DE3) |
Expression Temp | 37.0 |
Expression Time | 3 h |
Expression Vector | pET-PSKP-1 |
Expression Protocol | PSKP-1 encoding DNA was custom synthesized and ligated into a cloning vector by Interactiva Inc. (Ulm, Germany). Codon usage was optimized for expression in E. coli[22]. The fragment encoding recombinant PSKP-1 was subcloned into pET-15b (Novagen) at NcoI and BamHI sites. The resulting expression vector, pET-PSKP-1, was sequenced to confirm the reading frame and the identity of the insert. For expression, E. coli BL21 (DE3) cells were transformed with pET-PSKP-1 and grown to saturation [overnight at 37 °C in LB (Luria–Bertani) broth containing 100 mg·mL−1 ampicillin). The saturated culture (2 mL) was used to inoculate 1 L of fresh broth, and growth was continued to reach an attenuance (D), at 600 nm, of ≈ 1. Then, either 1 mm isopropyl thio-β-d-galactoside or 1% (w/v) lactose was added, and incubation continued for 3 h. Cells were harvested by centrifugation at 5000 g (10 min at 4 °C), and the resulting pellet was stored at −20 °C. As PSKP-1 was present in inclusion bodies, harvested cells (3–4 g) were suspended in 8 mL of lysis buffer (50 mm Tris/HCl, 100 mm NaCl, 1 mm EDTA, pH 8.0) and disrupted by sonication in an ice bath (in 4 mL fractions, five pulses of 30 s and 4 watts). |
Method of Induction | IPTG |
Cell Density at Induction | OD n/a = n/a |
Cell Disruption Method | Sonication |
Lytic Agent | Lysozyme |
Pre-Refolding Purification | not specified |
Solubility | insoluble |
Refolding | |
---|---|
Refolding Method | Dialysis |
Wash Buffer | n/a |
Solubilization Buffer | 20 mm sodium phosphate, 8 m urea, 2 mm glycine, 50 mm dithiothreitol, pH 7.5 |
Refolding Buffer | 20 mm sodium phosphate, 5.0 mm 2-mercaptoethanol, 0.5 mm cystamine, pH 7.5, and then exhaustively against distilled water |
Pre-Refolding Purification | not specified |
Tag Cleaved | no tag |
Refolding pH | 7.5 |
Refolding Temperature | 5.0 |
Protein Concentration | n/a |
Refolding Time | overnight |
Redox Agent | Beta-mercaptoethanol |
Redox Agent Concentration | 5 mM |
Refolding Protocol | Cleaned inclusion bodies were solubilized at 37 °C in buffer B (20 mm sodium phosphate, 8 m urea, 2 mm glycine, 50 mm dithiothreitol, pH 7.5) and loaded onto an SP Sepharose Fast-Flow (Pharmacia Biotech) cationic exchange column (1.5 × 5.0 cm) equilibrated with buffer B. Elution was performed with a 200 mL linear gradient of 0–0.5 m NaCl in buffer B. Fractions were monitored by absorbance at 280 nm and SDS/PAGE. Fractions containing pure PSKP-1 were dialyzed, first overnight at 5 °C against 100 volumes of 20 mm sodium phosphate, 5.0 mm 2-mercaptoethanol, 0.5 mm cystamine, pH 7.5, and then exhaustively against distilled water. Finally, particulate matter was removed by centrifugation (24 000 g, 20 min, 4 °C) and the solution fast-frozen to −80 °C and lyophilized. The resulting product was stored at −20 °C. |
Refolding Assay | Antibacterial activity assay |
Refolding Chaperones | None |
Refolding Additives | cystamine |
Additives Concentration | 0.5 mM |
Refolding Yield | 13 mg |
Purity | n/a |
Notes | n/a |